QingSong Health Corporation announced that, effective 30 June 2026, Mr. Gao Yushi, aged 43, will join the Board as an Executive Director. Gao currently serves as senior vice president of Guangdong Qingsongbao Insurance Brokerage Co., Ltd., overseeing the Group’s technology teams, and has more than 15 years of experience in artificial intelligence, big-data applications and technology management. His prior roles include senior vice-presidential and directorial positions at Beijing Qingsong Yikang Information Technology, Qufenqi (Beijing) Information Technology, Beijing Lianshang E-commerce and Meilishuo (Beijing) Network Technology, as well as project management at Baidu Online Network Technology.

Gao has signed a three-year service contract commencing 30 June 2026 and will not receive a director’s fee, benefits or bonuses from the Company. He holds 0.64 million underlying shares of QingSong Health, representing approximately 0.3% of the Company’s issued share capital, via options granted under the pre-IPO scheme. In accordance with the Company’s articles, he will stand for re-election at the next annual general meeting and will subsequently be subject to retirement by rotation.

Simultaneously, Non-Executive Directors Mr. Zheng Kaihuan and Mr. Zhao Yuping have tendered their resignations, also effective 30 June 2026, citing personal commitments. Both confirmed no disagreement with the Board and no matters requiring shareholder attention.

Following these changes, QingSong Health’s Board comprises two Executive Directors (Ms. Yang Yin and Mr. Gao Yushi), one Non-Executive Director (Mr. Wu Bin) and three Independent Non-Executive Directors (Dr. Wang Xiaoyan, Mr. Chow Yiu Ming and Ms. Ji Wenting).